Uncontrolled high blood pressure? Skip the salt

News  |  uk.reuters.com | Sep 19, 2008

NEW YORK (Reuters Health) - People who have uncontrolled high blood pressure despite taking multiple blood pressure-lowering drugs can lower their blood pressure by adopting a low-salt diet, according

http://uk.reuters.com/article/healthNews/idUKCOL97079020080919?feedType=RSS&feedName=healthNews

Sciele and Addrenex report positive results from Phase III ADHD study

News  |  www.pharmaceutical-business-review.com | Sep 11, 2008

Sciele Pharma and Addrenex Pharmaceuticals have announced that the preliminary analysis of the Phase III clinical study investigating the use of Clonicel for the treatment of attention deficit hyperactivity disorder has shown statistically significant improvement over placebo.

http://www.pharmaceutical-business-review.com/article_news.asp?guid=3028E187-A7F7-456F-A152-B085D3BD2038

Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD

News  |  www.biospace.com | Sep 11, 2008

DURHAM, N.C., Sept. 10 /PRNewswire/ -- A drug that diminishes the body's hyper-reactivity to stress has been shown to significantly reduce symptoms of attention-deficit hyperactivity disorder (ADHD) in children, according to a phase 3 clinical trial conducted by Addrenex Pharmaceuticals.

http://www.biospace.com/news_story.aspx?StoryID=109349&full=1

Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel for ADHD (Business Wire)

News  |  us.rd.yahoo.com | Sep 10, 2008

Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel for ADHD. - ATLANTA--(BUSINESS WIRE)--Sciele Pharma, Inc. (NASDAQ:SCRX - News) and Addrenex Pharmaceuticals today announced that the preliminary analysis of the Phase III clinical study investigating

http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080910/20080910006155.html?.v=1

NEJM early release: Tight BP control has to be continued in type 2 diabetics; otherwise benefits are not maintained.

News  |  content.nejm.org | Sep 10, 2008

Original Article from The New England Journal of Medicine -- Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes

http://content.nejm.org/cgi/content/full/NEJMoa0806359

VUMC to research blood pressure medication's effect on Type 2 diabetes

News  |  feeds.bizjournals.com | Sep 2, 2008

Vanderbilt University Medical Center diabetes researchers have launched a study examining whether a commonly prescribed blood pressure medication for treating high might help prevent or delay the onset of Type 2 diabetes.

http://feeds.bizjournals.com/~r/vertical_36/~3/381524788/daily6.html

Researchers devise means to create blood by discovering earliest form of human blood stem cells

News  |  www.news-medical.net | Aug 28, 2008

Johns Hopkins researchers have discovered the earliest form of human blood stem cells and deciphered the mechanism by which these embryonic stem cells replicate and grow. They also found a surprising biological marker that pinpoints these stem cells, which serve as the progenitors for red blood

http://www.news-medical.net/?id=41001

Diuretics just as effective in treating hypertension

News  |  www.imt.ie | Feb 5, 2008

ACE inhibitors appears to offer no advantages in improving clinical outcomes compared with use of diuretics when treating hypertension among individuals with metabolic syndrome, according to a new report.

http://www.imt.ie/clinical/cardiovascular/diuretics-just-as-effective-in.html

MedlinePlus Medical Encyclopedia: Renal perfusion scintiscan

A renal perfusion scintiscan is a nuclear medicine test that uses a small amount of a radioactive substance to get an image of the kidneys. The procedure also detects important narrowing of the arteries that supply the kidneys (renal artery stenosis).

http://www.nlm.nih.gov/medlineplus/ency/article/003831.htm

Flamel Technologies, Inc

COREG CR will utilize Flamel's proprietary Micropump(R) technology, which controls the delivery of carvedilol helping to maintain appropriate amounts of medicine in the body over a 24-hour span.

http://www.flamel.com/pressReleases/20061020.shtml